Medipharm Labs signs Costa Rica supply agreement

Executive Summary

• Medipharm Labs Corp. has signed a definitive supply agreement with Remidose Aerosols Inc. to supply GMP-certified medicinal cannabis products to the Costa Rican market.
• The agreement involves supplying oils, tinctures, metered dose inhalers, and dried flower to Remidose's affiliated entity, Remidose LATAM SRL.
• Costa Rica's medical cannabis market opened to regulated sales in June 2025 and is projected to exceed $35 million (U.S.) annually.

Key Details

• Parties Involved: Medipharm Labs Corp. (Supplier) and Remidose Aerosols Inc. / Remidose LATAM SRL (Buyer/Distributor).
• Product Scope: GMP-certified medicinal cannabis products, specifically oils, tinctures, metered dose inhalers, and dried flower.
• Market Context: Costa Rica's medical cannabis market officially opened to regulated sales in June 2025.
• Market Projection: The market is projected to exceed $35 million (U.S.) annually, driven by patient demand and a regulatory framework focused on product safety and GMP compliance.
• Regulatory Status: Remidose LATAM is fully licensed and authorized by Costa Rican health authorities to import medicinal cannabis products.
• Timeline: Shipments will begin once remaining regulatory requirements are completed.
• Strategic Rationale: Medipharm Labs aims to leverage its ability to navigate complex regulatory environments to expand international access to quality cannabis solutions. Remidose aims to provide high-quality, GMP-certified products to improve patient care in Costa Rica.

Notable Quotes

• David Pidduck, CEO of Medipharm Labs: "Medipharm Labs' proven ability to navigate complex regulatory environments enables us to deliver GMP-certified cannabinoid products to highly regulated markets worldwide. This agreement strengthens our commitment to supporting medical patients in Costa Rica and advancing international access to quality cannabis solutions."
• Michael Mayne, President of Remidose: "Remidose LATAM is proud to be fully licensed and authorized by Costa Rican health authorities to import medicinal cannabis products. Partnering with Medipharm Labs allows us to offer patients access to some of the highest-quality, GMP-certified cannabis products available globally. Medipharm's standards, reliability and proven ability to deliver in regulated markets make them the ideal partner for our mission to improve patient care in Costa Rica."